Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
platform
Biotech
Biotech investors tip toe around the bear to familiar bets
As the biotech industry claws its way out of a brutal bear market, investors are starting to pull their punches in preference for more sure bets.
Gabrielle Masson
,
Annalee Armstrong
,
Max Bayer
Jan 16, 2024 6:00am
Tandem begins full U.S. rollout of diabetes management platform
Dec 13, 2023 10:14am
Fluidigm scores $250M infusion and a new CEO
Jan 24, 2022 11:33am
Harvard's Nabla Bio nabs $11M for AI-driven antibody design
Dec 7, 2021 9:34am
Automated lab platform Opentrons closes $200M series C
Sep 23, 2021 10:10am